SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-005470
Filing Date
2021-11-12
Accepted
2021-11-12 08:00:13
Documents
15
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT xenetic_i8k.htm   iXBRL 8-K 29918
2 PRESS RELEASE xenetic_ex9901.htm EX-99.1 21126
3 GRAPHIC image_001.jpg GRAPHIC 6222
  Complete submission text file 0001683168-21-005470.txt   282916

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE xbio-20211112.xsd EX-101.SCH 3731
5 XBRL DEFINITION FILE xbio-20211112_def.xml EX-101.DEF 26583
6 XBRL LABEL FILE xbio-20211112_lab.xml EX-101.LAB 36561
7 XBRL PRESENTATION FILE xbio-20211112_pre.xml EX-101.PRE 25201
8 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i8k_htm.xml XML 5316
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 211399681
SIC: 2834 Pharmaceutical Preparations